Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-08-05AXSM144Herriot Tabuteau plan to sell securities of Axsome Therapeutics, Inc. under Form 144MEDIUM
Herriot Tabuteau filed Form 144 to notify SEC of plan to sell 45004 units of Axsome Therapeutics, Inc. securities around 2026-08-05, with aggregate market value of $9,579,101.40. The total outstanding units is 51459766.0. The amount planned to be sold represents 0.09% of total outstanding units; Recent transactions in ...
Large CapBiotechnology